Studies of Molecular Mechanisms Underlying Cardioprotective Action of the ALM-802 Compound
- 16 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bulletin of Experimental Biology and Medicine
- Vol. 170 (3), 312-315
- https://doi.org/10.1007/s10517-021-05058-x
Abstract
The mechanisms underlying cardioprotective activity of compound ALM-802 were studied in experiments on rats with chronic post-infarction heart failure. Real-time PCR showed that compound ALM-802 (daily intraperitoneal injections in a dose of 2 mg/kg for 28 days starting from day 91 after myocardial infarction modeling) restored the expression of genes encoding β1- (p=0.00001) and β2-adrenoreceptors (p=0.01) and type 2 ryanodine receptors (p=0.008) in the myocardium that was reduced in control animals. These effects can serve as the basis for the ability of the compound to reduce the intensity of remodeling and increase the inotropic function of the left heart ventricle shown earlier in this model.Keywords
This publication has 12 references indexed in Scilit:
- Metabolic Coordination of Physiological and Pathological Cardiac RemodelingCirculation Research, 2018
- Metabolic remodelling in heart failureNature Reviews Cardiology, 2018
- Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart FailureDiseases, 2017
- Arrhythmogenic and metabolic remodelling of failing human heartJournal Of Physiology-London, 2016
- Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failureInternational Journal of Cardiology, 2015
- Calcium and IP3 dynamics in cardiac myocytes: experimental and computational perspectives and approachesFrontiers in Pharmacology, 2014
- The IP 3 Receptor Regulates Cardiac Hypertrophy in Response to Select StimuliCirculation Research, 2010
- The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytesJournal Of Physiology-London, 2007
- Epac-mediated Activation of Phospholipase Cɛ Plays a Critical Role in β-Adrenergic Receptor-dependent Enhancement of Ca2+ Mobilization in Cardiac MyocytesOnline Journal of Public Health Informatics, 2007
- Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure.European Journal of Heart Failure, 2003